India, April 22 -- Embraer S.A. (ERJ), a Brazilian aerospace company, reported a US$26.4 billion backlog in the first quarter of 2025 up 25% from the prior year. The company delivered 30 aircraft in ... Read More
India, April 22 -- T-Mobile US, Inc. (TMUS), Tuesday announced new plans along with Metro with a guarantee of same price of talk, text and data for five years. The company will introduce Experience M... Read More
India, April 22 -- Indian shares may open higher on Wednesday as optimism grew over a potential easing of trade tensions between the U.S. and China. Investors may also react favorably to reports sugg... Read More
India, April 22 -- The manufacturing sector in Japan continued to contract in April, albeit at a slower rate, the latest survey from Jibun Bank revealed on Wednesday with a manufacturing PMI score of ... Read More
India, April 22 -- MSCI Inc. (MSCI) will host a conference call at 11:00 AM ET on April 22, 2025, to discuss Q1 25 earnings results. MSCI Inc. is scheduled to report results on Tuesday, April 22, befo... Read More
India, April 22 -- Lockheed Martin Corp. (LMT) will host a conference call at 11:00 AM ET on April 22, 2025, to discuss Q1 25 earnings results. To access the live webcast, log on to https://investors... Read More
India, April 22 -- Shares of Tivic Health Systems, Inc. (TIVC) more than tripled on Tuesday morning after the company announced positive interest from the White House and the U.S. FDA in potential mil... Read More
India, April 22 -- TIGO ENERGY, INC. (TYGO) released Loss for its first quarter of -$26.80 million The company's earnings totaled -$26.80 million, or -$0.44 per share. This compares with -$14.77 mill... Read More
India, April 22 -- Federal Signal Corp. (FSS) announced that its board has authorized an additional stock repurchase program of up to $150 million of the company's common stock. The repurchase program... Read More
India, April 22 -- Akeso Inc. announced that its PD-1/VEGF bispecific antibody, ivonescimab, in combination with chemotherapy, has demonstrated strongly positive results in the Phase III clinical tria... Read More